Kasaro Margaret Phiri, Sindano Ntazana, Chinyama Manze, Mudenda Mayaba, Chilaisha Florence, Price Joan T, Chileshe Modesta
University of North Carolina Global Projects Zambia, Lusaka, Zambia.
Division of Global Women's Health, Department of Obstetrics and Gynecology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Front Reprod Health. 2021 Jul 13;3:684717. doi: 10.3389/frph.2021.684717. eCollection 2021.
The WHO guideline on the integration of family planning (FP) and pre-exposure HIV prophylaxis (PrEP) to enhance the health of women and adolescent girls is reflected in the Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection, 2020. There is however a dearth of data on the integration of PrEP and FP in Zambia. We describe the integration of oral PrEP in FP services using the Evidence for Contraceptive Options and HIV Outcomes (ECHO) study experience at Kamwala District Health Center in Lusaka, Zambia. The provision of oral PrEP at Kamwala started in October 2017, lasting for ~11 months, and utilized the model where initial processes to offer PrEP were on-site followed by off-site referral to laboratory and PrEP provider services. The characteristics of 658 women who enrolled in ECHO at Kamwala are representative of women accessing FP services in Lusaka. About 644 of the enrollees were offered oral PrEP. The proportion of women accepting PrEP was low at 1.08% and the proportion of study visits at which PrEP was requested was also low at 0.57%. Those who accepted PrEP were above 20 years old, married, with at least primary education, sexual behavior, and risk comparable to decliners. The ECHO study experience indicates that the setup and integration of oral PrEP and FP services are feasible in the setting. However, uptake of PrEP was very low. Possible contributory factors were as follows: (1) timing of introduction of PrEP midway in the study, (2) PrEP being a new intervention, (3) challenges of autonomy of young women to include a daily pill into their lives and anticipated challenges to adherence because of fear of adverse events, (4) possible underdetermined risk due to use of an unvalidated risk assessment tool and assessment by health care provider vs. self-assessment, and (5) extra layer of challenges to negotiate due to needing for off-site referrals. Following these findings, we conclude that further research through demonstration projects of integration of oral PrEP and FP may provide solutions to low uptake. This information is critical for scaling up of integration HIV prevention services and sexual and reproductive health (SRH) services.
世界卫生组织关于将计划生育(FP)与暴露前预防艾滋病(PrEP)相结合以增进妇女和少女健康的指南体现在《赞比亚2020年艾滋病毒感染治疗与预防综合指南》中。然而,赞比亚缺乏关于PrEP与FP整合的数据。我们利用赞比亚卢萨卡卡姆瓦拉区卫生中心的避孕选择与艾滋病毒结果证据(ECHO)研究经验,描述了口服PrEP在FP服务中的整合情况。卡姆瓦拉区于2017年10月开始提供口服PrEP,持续约11个月,并采用了一种模式,即提供PrEP的初始流程在现场进行,随后将患者转至场外进行实验室检查和PrEP提供者服务。在卡姆瓦拉区参加ECHO研究的658名妇女的特征代表了在卢萨卡获得FP服务的妇女。约644名参与者被提供了口服PrEP。接受PrEP的妇女比例较低,为1.08%,要求进行PrEP的研究访视比例也较低,为0.57%。接受PrEP的妇女年龄在20岁以上,已婚,至少接受过小学教育,性行为和风险与拒绝者相当。ECHO研究经验表明,在该环境中设置和整合口服PrEP与FP服务是可行的。然而,PrEP的接受率非常低。可能的促成因素如下:(1)在研究中途引入PrEP的时间;(2)PrEP是一种新的干预措施;(3)年轻女性将每日服药纳入生活的自主权挑战以及因担心不良事件而预期的依从性挑战;(4)由于使用未经验证的风险评估工具以及由医疗保健提供者进行评估与自我评估,可能存在风险评估不足的情况;(5)由于需要场外转诊而带来的额外协商挑战。基于这些发现,我们得出结论,通过口服PrEP与FP整合的示范项目进行进一步研究可能会为低接受率问题提供解决方案。这些信息对于扩大艾滋病毒预防服务与性健康和生殖健康(SRH)服务的整合至关重要。